SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS - News), a specialty pharmaceutical company, today reported financial and operating results for the quarter ended September 30, 2007. The company also announced that it has lowered its net loss guidance for 2007, now estimated at or below $55 million. Key financial results for the third quarter of 2007 included:
